Treatment of Pyelonephritis with Frank Hematuria

Initial Assessment and Diagnosis

The European Urology guidelines recommend prompt differentiation between uncomplicated and potentially obstructive pyelonephritis, as obstructive pyelonephritis can rapidly progress to urosepsis 1
Frank hematuria in pyelonephritis suggests a complicated infection that may involve urinary tract obstruction, renal stones, or other structural abnormalities, according to the European Urology guidelines 1
Urine culture and antimicrobial susceptibility testing should be performed in all cases before initiating antibiotics, as recommended by the European Urology guidelines 1
Upper urinary tract imaging (ultrasound or CT) should be performed urgently to rule out obstruction, abscess, or stone disease, particularly when frank hematuria is present, according to the European Urology guidelines 1

The European Urology guidelines recommend intravenous antimicrobial therapy with a fluoroquinolone, an aminoglycoside (with or without ampicillin), an extended-spectrum cephalosporin, or a carbapenem, followed by oral therapy based on susceptibility testing 1, 2
For hospitalized patients with frank hematuria, the European Urology guidelines recommend initial empiric therapy with ciprofloxacin 400 mg twice daily, levofloxacin 750 mg once daily, ceftriaxone 1-2 g once daily, cefotaxime 2 g three times daily, piperacillin/tazobactam 2.5-4.5 g three times daily, or an aminoglycoside (gentamicin 5 mg/kg once daily or amikacin 15 mg/kg once daily) with or without ampicillin 1, 2
For outpatients with mild hematuria, the Clinical Infectious Diseases guidelines recommend oral therapy with ciprofloxacin 500-750 mg twice daily for 7 days, levofloxacin 750 mg once daily for 5 days, or an initial intravenous dose of a long-acting parenteral antimicrobial (e.g., ceftriaxone 1 g) before starting oral therapy 2

The European Urology guidelines suggest that frank hematuria indicates a complicated UTI that may require longer treatment duration and more aggressive management 1
The Clinical Infectious Diseases guidelines recommend considering complications such as urinary tract obstruction, renal abscess, or renal stones in patients with hematuria 2

The Clinical Infectious Diseases guidelines recommend that local resistance patterns should guide empiric therapy selection, and if fluoroquinolone resistance exceeds 10% locally, initial parenteral therapy with a broad-spectrum agent is recommended 2
The European Urology guidelines recommend reserving carbapenems and novel broad-spectrum antimicrobials for patients with multidrug-resistant organisms 1
The Clinical Infectious Diseases guidelines recommend tailoring therapy based on culture and susceptibility results as soon as available 2

The Infectious Diseases Society of America recommends trimethoprim-sulfamethoxazole (14-day course) as an alternative option if fluoroquinolones cannot be used, if the pathogen is known to be susceptible 3

The guideline society suggests that local resistance patterns should guide empiric therapy selection, although the specific recommendation is not provided in the cited text, an alternative option is provided for when fluoroquinolone resistance exceeds 10% locally 3